Many hospitals across the province, both smaller ones in rural areas and large ones in cities, have been overwhelmed with patients, reporting large volumes and long waits.
Having previously updated the risks specified on the product monograph for one type of Janus Kinase inhibitor, Health Canada now says it can't rule out similar risks for other types.